Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracameral amphotericin B versus voriconazole for fungal keratitis
RBR-6rvjd2Phase 2Recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of voriconazole and amphotericin b in keratomycosis (2 arms), sponsored by Federal University of São Paulo. Started Dec 2019; status: recruiting.
02
Drugs
voriconazoleamphotericin b
03
Conditions
keratomycosis
Beyond the preview
Go deeper on RBR-6rvjd2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6rvjd2.